{"nctId":"NCT00539240","briefTitle":"Role of Pain Modulation in GERD Patients Who Failed Standard Dose PPI","startDateStruct":{"date":"2006-04"},"conditions":["Gastroesophageal Reflux Disease"],"count":236,"armGroups":[{"label":"Rabeprazole morning/evening placebo bedtime","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Rabeprazole 20 mg two times, Placebo at bedtime"]},{"label":"Rabeprazole breakfast, placebo dinner and bedtime","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Rabeprazole 20mg, placebo dinner and bedtime"]},{"label":"Rabeprazole breakfast, placebo dinner, nortriptyline bedtime","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Rabeprazole 20mg,placebo dinner ,Low dose Tricyclic Antidepressant"]}],"interventions":[{"name":"Rabeprazole 20mg, placebo dinner and bedtime","otherNames":["AcipHex"]},{"name":"Rabeprazole 20 mg two times, Placebo at bedtime","otherNames":["Aciphex"]},{"name":"Rabeprazole 20mg,placebo dinner ,Low dose Tricyclic Antidepressant","otherNames":["Nortriptyline and Aciphex"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Currently being treated with a PPI, but continue to experience GERD symptoms (such as heartburn) at least 2 times per week.\n\nExclusion Criteria:\n\n* Known allergy or intolerance to TCA\n* History of serious arrhythmia or use of anti-arrhythmics\n* History of seizures\n* Subjects with significant co-morbidity, e.g., cardiovascular, respiratory, urogenital, renal, gastrointestinal, hepatic, hematological, endocrine, neurologic or psychiatric\n* With evidence or history of drug abuse within the past 6 months\n* Erosive esophagitis, esophageal ulceration, peptic stricture, Barrett's esophagus or adenocarcinoma of the esophagus on endoscopy\n* History of esophagogastric surgery\n* Gastric or duodenal lesions (ulcer, tumor, etc.)\n* Women who are pregnant or of childbearing age who are not on contraception\n* Patients who are unwilling or unable to provide informed consent\n* Insulin dependent diabetes","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"80 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Daytime Heartburn, Number of Days in Week Symptoms Intensity Score < 3 (Better)","description":"the number of days with Symptom Intensity Score \\< 3 (better) for daytime heartburn during week 6 as compared to baseline","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.6","spread":"0.9"},{"groupId":"OG001","value":"5.9","spread":"2.2"},{"groupId":"OG002","value":"6.1","spread":"1.8"}]}]}]},{"type":"SECONDARY","title":"Health Related Quality of Life","description":"SF-36 Physical Component Score (higher number better quality of life), is a measure of overall physical quality of life distinct from mental health. The range is 0 - 100. It has been adjusted to US national norms so that a score of 50 corresponds to the national mean.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"42.0","spread":"10.3"},{"groupId":"OG001","value":"37.7","spread":"11.0"},{"groupId":"OG002","value":"37.7","spread":"11.0"}]}]}]},{"type":"PRIMARY","title":"Nighttime Heartburn, Number of Days in Week Symptom Activity Score <3 (Better) in Week 6 Compared to Baseline","description":"the number of days with Symptom Intensity Score \\< 3 (better) for nighttime heartburn during week 6 as compared to baseline","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.6","spread":"0.9"},{"groupId":"OG001","value":"5.8","spread":"2.0"},{"groupId":"OG002","value":"6.0","spread":"1.6"}]}]}]},{"type":"PRIMARY","title":"Acid Regurgitation, Number of Days in Week Symptoms Intensity Score < 3 (Better)","description":"the number of days with Symptom Intensity Score \\< 3 (better) for acid regurgitation during week 6 as compared to baseline","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.7","spread":"0.8"},{"groupId":"OG001","value":"5.9","spread":"2.1"},{"groupId":"OG002","value":"6.3","spread":"1.4"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":59},"commonTop":["Somnolence","Constipation","Dry mouth","Blurred vision","Flu like symptoms"]}}}